AMT-130 for Huntington's Disease

Learn more about how AMT-130 aims to "silence" the huntingtin gene.

Go To Site


HDSA HD Trial Finder

This clinical trial tool will help you find Huntington's disease experiments currently taking place.

Go To Site


HDSA Clinical Pipeline

Learn about drugs that are currently in development or in clinical trials for HD

Go To Site


VX15

VX15 may have the potential to slow the progression of brain inflammation, which has been shown to impair thinking, movement, and behavior in HD animal models. VX15 has not been approved by the FDA; its potential benefits for HD are being investigated within the SIGNAL trial.

Go To Site


Laquinimod

Laquinimod is an investigational drug being studied to see if it may have an effect on the symptoms of HD, including abnormal movements, memory problems, and emotional disorders.

Go To Site


SRX246

SRX246 is an experimental treatment for symptoms of irritability in Huntington's disease.

Go To Site